October 2022 Journal Issue | GU Oncology Now

GU Oncology Now Journal: October 2022 Issue

GU Oncology Now Journal: October 2022 Issue

Editor's Talk

Immunotherapy and Cell-Based Therapies for Patients With Prostate Cancer

Conversations With The Uromigos

The Uromigos Episode 184: Active Surveillance and the Seeds of Doubt

Profiles in GU Oncology

Profiles in GU Oncology: Preston C. Sprenkle, MD

Features

Intravesical Immunotherapy in the Management of NMIBC

The Role of PET/CT in Metastatic Renal Cell Carcinoma

Hereditary RCC: Presentations and Approaches to Treatment

Ablation Therapy Versus Partial Nephrectomy for Renal Cancers

Cover Story

The Past, Present, and Future of Focal Therapy Use

ESMO 2022

Updated Results From the Phase 3 PROpel Trial

Overall Survival Results of STAMPEDE Protocol Phase 3 Trials

GU Oncology Now Journal: October 2022 Issue

Advertisement

Advertisement

Editorial Advisory Board

Catherine H. Marshall, MD, MPHEditor | Assistant Professor of Oncology at the Johns Hopkins University School of Medicine

Jérémie Calais, MD, PhDEditor | Director of the Theranostics and Clinical Research Programs at the University of California, Los Angeles

Akhil Abraham Saji, MDEditor | Urologist at Swedish Health Services

David Ambinder, MDEditor | Urology Resident at New York Medical College/Westchester Medical Center